Daniel Huertas - Concepedia

Author

Daniel Huertas

Bellvitge University Hospital

Also Known As

Daniel Huertas, Huertas, Daniel

Publications

258

Citations

H-Index

Concepts

All Affiliations

Bellvitge University Hospital Institut d'Investigació Biomédica de Bellvitge Universitat de Barcelona Centre for Biomedical Network Research on Rare Diseases Deleted Institution

About

Daniel Huertas is an author at Bellvitge University Hospital specializing in medicine, radiation oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	55
2	Pharmacology	1	1	20
3	Pulmonary Disease	1	1	35
4	Pulmonary Medicine	1	1	35
5	Cancer Therapeutics	1	1	20

Daniel Huertas

Publications

234

Citations

H-Index

Page 1

	Year	Citations
High Prevalence of Left Ventricle Diastolic Dysfunction in Severe COPD Associated with A Low Exercise Capacity: A Cross-Sectional Study Marta López‐Sánchez, Mariana Muñoz‐Esquerre, Daniel Huertas, PLoS ONE	2013	68
Roflumilast added to triple therapy in patients with severe COPD: A real life study Mariana Muñoz‐Esquerre, Marta Díez-Ferrer, Concepción Montón, Pulmonary Pharmacology & Therapeutics Severe CopdAdvanced Lung DiseasePulmonary PharmacologyPulmonary MedicineReal Life Study	2014	35
Systemic and Pulmonary Vascular Remodelling in Chronic Obstructive Pulmonary Disease Mariana Muñoz‐Esquerre, Marta López‐Sánchez, Ignacio Escobar, PLoS ONE	2016	27
Genetic Adaptation and Acquisition of Macrolide Resistance in Haemophilus spp. during Persistent Respiratory Tract Colonization in Chronic Obstructive Pulmonary Disease (COPD) Patients Receiving Long-Term Azithromycin Treatment Anna Carrera-Salinas, Aída González-Díaz, Rachel Ehrlich, Microbiology Spectrum	2022	23
Pharmacokinetics of 2-methyl-9-hydroxyellipticinium acetate (NSC-264137) in cancer patients (phase I study) Alain Gouyette, Daniel Huertas, Jean‐Pierre Droz, European Journal of Cancer and Clinical Oncology OncologyMedicine2-Methyl-9-hydroxyellipticinium AcetatePharmacotherapyAnti-cancer Agent	1982	20
Impact of acute exacerbations on platelet reactivity in chronic obstructive pulmonary disease patients Mariana Muñoz‐Esquerre, José Luis Ferreiro, Daniel Huertas, International Journal of COPD	2017	16
Inflammatory markers and circulating extracellular matrix proteins in patients with chronic obstructive pulmonary disease and left ventricular diastolic dysfunction Marta López‐Sánchez, Mariana Muñoz‐Esquerre, Daniel Huertas, The Clinical Respiratory Journal	2015	14
Is the purinergic pathway involved in the pathology of COPD? Decreased lung CD39 expression at initial stages of COPD Elisabet Aliagas, Mariana Muñoz‐Esquerre, Ester Cuevas, Respiratory Research	2018	11
Effectiveness of a Respiratory Day Hospital Program to Reduce Admissions for Exacerbation in Patients with Severe COPD: A Prospective, Multicenter Study Daniel Huertas, Concepción Montón, Alicia Marín, COPD Journal of Chronic Obstructive Pulmonary Disease	2017	10
Systemic and functional effects of continuous azithromycin treatment in patients with severe chronic obstructive pulmonary disease and frequent exacerbations Ester Cuevas, Daniel Huertas, Concepción Montón, Frontiers in Medicine	2023	10

Page 1